Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a

Details Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a

1994-10-21

1996-06-18

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31425

Patent

active

055278140

ABSTRACT:
Use of 2-amino-6-(trifluoromethoxy)benzothiazole, or a salt of this compound with a pharmaceutically acceptable acid, for obtaining a medicament intended for the treatment of motor neuron diseases, in particular amyotrophic lateral sclerosis, and especially amyotrophic lateral sclerosis with early bulbar involvement or the bulbar form of the disease.

REFERENCES:
patent: 4370338 (1983-01-01), Mizoule et al.
patent: 4826860 (1989-05-01), Johnson et al.
patent: 4906649 (1990-03-01), Blanchard et al.
patent: 4918090 (1990-04-01), Johnson et al.
patent: 4980356 (1990-12-01), Audiau et al.
patent: 5026717 (1991-06-01), Audiau et al.
patent: 5236940 (1993-08-01), Audiau et al.
Chemical Abstracts 109:31973t, 1988, Stutzmann et al.
Wyngaarden et al. (Editors), Cecil Textbook of Medicine (19th Edition), W. B. Saunders Co., Philadelphia, Pa., 1992, pp. 2140-2142.
The Lancet, vol. 341, Jan. 30, 1993, pp. 265-268, "Cell Culture Evidence for Neuronal Degeneration . . . ", Philippe Couratier et al.
Mayo Clinic Proc., vol. 66, Jan. 1991, pp. 54-82, "Motor Neuron Disease (Amyotrophic Lateral Sclerosis)", David B. Williams et al.
Rhone-Poulenc Rorer, Business News Management Decisions & Results, Apr. 4, 1995, "RILUTEK.RTM. Results of a Phase III Clinical Trial . . . ".
Rhone-Poulenc Rorer, For Immediate Release, "Impact of Rilutek.TM. On Survival In Amyotrophic Lateral Sclerosis (ALS) Confirmed . . . " Apr. 4, 1995.
The Journal of Neuroscience, vol. 9, No. 11, Nov. 1989, pp. 3720-3737 "Riluzole, A Novel Antigultamate, Prevents Memory Loss and Hippocampal Neuronal Damage in Ischemic Gerbils", C. Malgouris, et al.
British Journal of Pharmacology, vol. 97, p. 583P, "Riluzole Antagonises Excitatory Amino Acid-Evoked Firing in Rat Facial Motoneurones in Vivo", D. Girdlestone, et al, 1987.
Therapie, vol. 45, No. 3, 1990, pp. 277-279, "Excitotoxins and Amyotrophic Lateral Sclerosis", Th. L. Munsat, et al.
Ann Neurol, vol. 22, No. 5, 1987, pp. 575-579, "Abnormal Glutamate Metabolism in Amyotrophic Lateral Sclerosis", A. Plaitakis, et al.
Neurology, vol. 41, No. 3, Supplement 1, 1991 pp. 392-393, "Dysregulation of Glutamate Metabolism in ALS: Correlation With Gender and Disease Type", A. Plaitakis, et al.

Affiliated with

Also associated with

Rating

Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-223192